Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer

Clinical trial NCT00253370 · COMPLETED

Trial details

NCT number: NCT00253370
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Gastroesophageal Junction Metastatic Gastric Cancer Advanced Unresectable Gastric Cancer

Start date: 2005-10-01
Primary completion: 2008-05-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.